🚀 VC round data is live in beta, check it out!
OrganoClick Valuation Multiples
Discover revenue and EBITDA valuation multiples for OrganoClick and similar public comparables like Directa Plus, Hulytego, Serstech, Plasticos Compuestos and more.
OrganoClick Overview
About OrganoClick
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
Founded
2006
HQ
Employees
40
Website
Sectors
Financials (LTM)
EV
$19M
OrganoClick Financials
OrganoClick reported last 12-month revenue of $12M and negative EBITDA of ($753K).
In the same LTM period, OrganoClick generated $2M in gross profit, ($753K) in EBITDA losses, and had net loss of ($3M).
Revenue (LTM)
OrganoClick P&L
In the most recent fiscal year, OrganoClick reported revenue of $12M and EBITDA of ($1M).
OrganoClick expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $12M | XXX | $12M | XXX | XXX | XXX |
| Gross Profit | $2M | XXX | $2M | XXX | XXX | XXX |
| Gross Margin | 17% | XXX | 14% | XXX | XXX | XXX |
| EBITDA | ($753K) | XXX | ($1M) | XXX | XXX | XXX |
| EBITDA Margin | (6%) | XXX | (12%) | XXX | XXX | XXX |
| EBIT Margin | (23%) | XXX | (28%) | XXX | XXX | XXX |
| Net Profit | ($3M) | XXX | ($4M) | XXX | XXX | XXX |
| Net Margin | (28%) | XXX | (33%) | XXX | XXX | XXX |
| Net Debt | — | — | $6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
OrganoClick Stock Performance
OrganoClick has current market cap of $10M, and enterprise value of $19M.
Market Cap Evolution
OrganoClick's stock price is $0.09.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19M | $10M | -3.6% | XXX | XXX | XXX | $-0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOrganoClick Valuation Multiples
OrganoClick trades at 1.6x EV/Revenue multiple, and (25.6x) EV/EBITDA.
EV / Revenue (LTM)
OrganoClick Financial Valuation Multiples
As of April 19, 2026, OrganoClick has market cap of $10M and EV of $19M.
Equity research analysts estimate OrganoClick's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
OrganoClick has a P/E ratio of (3.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $10M | XXX | $10M | XXX | XXX | XXX |
| EV (current) | $19M | XXX | $19M | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | (25.6x) | XXX | (13.8x) | XXX | XXX | XXX |
| EV/EBIT | (7.0x) | XXX | (5.7x) | XXX | XXX | XXX |
| EV/Gross Profit | 9.5x | XXX | 11.9x | XXX | XXX | XXX |
| P/E | (3.1x) | XXX | (2.6x) | XXX | XXX | XXX |
| EV/FCF | (11.8x) | XXX | (9.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified OrganoClick Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
OrganoClick Margins & Growth Rates
OrganoClick's revenue in the last 12 month grew by 6%.
OrganoClick's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
OrganoClick's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
OrganoClick's rule of X is 26% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
OrganoClick Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | (6%) | XXX | (12%) | XXX | XXX | XXX |
| EBITDA Growth | (259%) | XXX | (169%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 15% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 26% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 23% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 14% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 5% | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 42% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
OrganoClick Public Comps
See public comps and valuation multiples for other Chemicals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| OrganoClick | XXX | XXX | XXX | XXX | XXX | XXX |
| Directa Plus | XXX | XXX | XXX | XXX | XXX | XXX |
| Hulytego | XXX | XXX | XXX | XXX | XXX | XXX |
| Serstech | XXX | XXX | XXX | XXX | XXX | XXX |
| Plasticos Compuestos | XXX | XXX | XXX | XXX | XXX | XXX |
| Sinteza | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
OrganoClick M&A Activity
OrganoClick acquired XXX companies to date.
Last acquisition by OrganoClick was on XXXXXXXX, XXXXX. OrganoClick acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by OrganoClick
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOrganoClick Investment Activity
OrganoClick invested in XXX companies to date.
OrganoClick made its latest investment on XXXXXXXX, XXXXX. OrganoClick invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by OrganoClick
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout OrganoClick
| When was OrganoClick founded? | OrganoClick was founded in 2006. |
| Where is OrganoClick headquartered? | OrganoClick is headquartered in Sweden. |
| How many employees does OrganoClick have? | As of today, OrganoClick has over 40 employees. |
| Is OrganoClick publicly listed? | Yes, OrganoClick is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of OrganoClick? | OrganoClick trades under ORGC ticker. |
| When did OrganoClick go public? | OrganoClick went public in 2015. |
| Who are competitors of OrganoClick? | OrganoClick main competitors are Directa Plus, Hulytego, Serstech, Plasticos Compuestos. |
| What is the current market cap of OrganoClick? | OrganoClick's current market cap is $10M. |
| What is the current revenue of OrganoClick? | OrganoClick's last 12 months revenue is $12M. |
| What is the current revenue growth of OrganoClick? | OrganoClick revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of OrganoClick? | Current revenue multiple of OrganoClick is 1.6x. |
| Is OrganoClick profitable? | No, OrganoClick is not profitable. |
| What is the current EBITDA of OrganoClick? | OrganoClick has negative EBITDA and is not profitable. |
| What is OrganoClick's EBITDA margin? | OrganoClick's last 12 months EBITDA margin is (6%). |
| What is the current EV/EBITDA multiple of OrganoClick? | Current EBITDA multiple of OrganoClick is (25.6x). |
| What is the current FCF of OrganoClick? | OrganoClick's last 12 months FCF is ($2M). |
| What is OrganoClick's FCF margin? | OrganoClick's last 12 months FCF margin is (14%). |
| What is the current EV/FCF multiple of OrganoClick? | Current FCF multiple of OrganoClick is (11.8x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.